Trial NCT04605094

View at ClinicalTrials.gov 
Org. Study IDs: D3256C00001

Last trial update was posted on 2023-08-31

MeSH Interventions

Benralizumab

MeSH Conditions

Dermatitis Dermatitis, Atopic Eczema

Other Conditions

Atopic Dermatitis

Stopping Reasons

The study did not meet the primary endpoint.

Limitations And Caveats

The study was terminated as the study did not support the continued development of benralizumab for the indication of AD.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID